These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16022663)

  • 1. Blast from the past: the aluminum's ghost on the lanthanum salts.
    Canavese C; Mereu C; Nordio M; Sabbioni E; Aime S
    Curr Med Chem; 2005; 12(14):1631-6. PubMed ID: 16022663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanum carbonate as a first-line phosphate binder: the "cons".
    Drüeke TB
    Semin Dial; 2007; 20(4):329-32. PubMed ID: 17635823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for hyperphosphatemia.
    Bellinghieri G; Santoro D; Savica V
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):355-65. PubMed ID: 17874966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
    Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Introduction to lanthanum carbonate: pharmacology, safety and tolerability].
    Rodríguez Portillo M
    Nefrologia; 2008; 28 Suppl 5():7-10. PubMed ID: 18847413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanthanum carbonate--a first line phosphate binder?
    de Freitas D; Donne RL; Hutchison AJ
    Semin Dial; 2007; 20(4):325-8. PubMed ID: 17635822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients.
    Albaaj F; Hutchison AJ
    Int J Clin Pract; 2005 Sep; 59(9):1091-6. PubMed ID: 16115187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanthanum carbonate: safety data after 10 years.
    Hutchison AJ; Wilson RJ; Garafola S; Copley JB
    Nephrology (Carlton); 2016 Dec; 21(12):987-994. PubMed ID: 27479781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanthanum carbonate: a new phosphate binder.
    Behets GJ; Verberckmoes SC; D'Haese PC; De Broe ME
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):403-9. PubMed ID: 15199290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era in phosphate binder therapy: what are the options?
    Salusky IB
    Kidney Int Suppl; 2006 Dec; (105):S10-5. PubMed ID: 17136110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiographic characteristics of lanthanum carbonate absorption].
    Vrigneaud L; Lefèbvre D; Daem AO; Lemaitre V
    Nephrol Ther; 2008 Apr; 4(2):111-3. PubMed ID: 18243834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Lanthanum carbonate and new phosphate binders in patients with chronic kidney disease].
    Negi S; Shigematsu T
    Clin Calcium; 2010 Jul; 20(7):1096-102. PubMed ID: 20585189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients.
    Albaaj F; Hutchison AJ
    Expert Opin Pharmacother; 2005 Feb; 6(2):319-28. PubMed ID: 15757427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving phosphate-binder therapy as a way forward.
    Hutchison AJ
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i19-24. PubMed ID: 15126650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanthanum carbonate.
    Freemont AJ
    Drugs Today (Barc); 2006 Dec; 42(12):759-70. PubMed ID: 17285149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis.
    Finn WF; Joy MS;
    Curr Med Res Opin; 2005 May; 21(5):657-64. PubMed ID: 15969865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphate binder equivalent dose.
    Daugirdas JT; Finn WF; Emmett M; Chertow GM;
    Semin Dial; 2011; 24(1):41-9. PubMed ID: 21338393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lanthanum carbonate in clinical practice].
    Torregrosa Prats V
    Nefrologia; 2008; 28 Suppl 5():11-4. PubMed ID: 18847414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lanthanum carbonate: time to abandon prejudices?
    Brancaccio D; Cozzolino M
    Kidney Int; 2007 Feb; 71(3):190-2. PubMed ID: 17252028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.